Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

The importance of doing HIV research in developing countries

Abstract

Should scarce resources be spent on biomedical research into HIV/AIDS in countries that cannot afford anti-retroviral therapy for all their patients, or should all available resources be allocated to direct patient care rather than to research?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Hogg, R., Anis, A., Weber, A., O'Shaughnessy, M. & Schechter, M. Triple-combination anti-retroviral therapy in sub-Saharan Africa. Lancet 350, 1406 (1997).

    Article  CAS  Google Scholar 

  2. Gilson, L. et al. Cost-effectiveness of improved treatment services for sexually transmitted in preventing HIV-1 infection in Mwanza region, Tanzania. Lancet 350, 1805–1809 (1997).

    Article  CAS  Google Scholar 

  3. Grosskurth, H. et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomized controlled trial. Lancet 346, 530–536 (1995).

    Article  CAS  Google Scholar 

  4. Abdool-Karim, Q., Tarantola, D., Sy, E.A. & Moodie, R. Government responses to HIV/AIDS in Africa: what have we learnt? AIDS 11, S143–149 (1997).

    PubMed  Google Scholar 

  5. Connor, E., Sperling, R. & Gelber, R. Reduction of maternal-infant transmission of human immunodeficiency type 1 with zidovudine treatment. N. Engl. J. Med. 331, 1171–1180 (1994).

    Google Scholar 

  6. Hofmeyr, G. & McIntyre, J. Preventing perinatal transmissions. Br. Med. J. 315, 199–200 (1997).

    Article  CAS  Google Scholar 

  7. Newell, M.-L., Gray, G. & Bryson, Y. Prevention of mother-to-child transmission of HIV-1 infection. AIDS 11, S165–S172 (1997).

    PubMed  Google Scholar 

  8. Coutsoudis, A. et al. Effects of vitamin A supplementation on viral load in HIV-1 infected pregnant women. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 15, 86–87 (1997).

    Article  CAS  Google Scholar 

  9. Biggar, R. et al. Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet 347, 1647–1650 (1996).

    Article  CAS  Google Scholar 

  10. Sulkowski, M. et al. The effect of acute infections on plasma HIV-1 viral load and the expression of serological markers of immune activation among HIV-infected adults. J. Infect. Dis. (in the press).

  11. Golletti, D. et al. Effect of Mycobacterium tuberculosis on HIV replication: role of immune activation. J. Immunol. 157, 1271–1278 (1996).

    Google Scholar 

  12. Bush, C., Donovan, R., Markowitz, N., Kvale, P. & Saravolatz, L. A study of HIV RNA viral load in AIDS patients with bacterial pneumonia. J. Acqir. Immune Defic. Syndr. Hum. Retrovirol. 13, 23–26 (1996).

    Article  CAS  Google Scholar 

  13. Donovan, R., Bush, C., Markowitz, N., Baxan, D. & Saravolatz, L. Changes in viral load markers during AIDS-associated opportunistic diseases in human immunodeficiency virus-infected persons. J. Infect. Dis. 174, 401–403 (1996).

    Article  CAS  Google Scholar 

  14. Mole, L., Ripich, S., Margolis, D. & Holodniy, M. The impact of active herpes simplex infections on human immunodeficiency virus. J. Infect. Dis. 176, 766–770 (1997).

    Article  CAS  Google Scholar 

  15. Vuthipongse, P. et al. Administration of Zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission-Thailand, 1996-1998. MMWR 47, 151–154 (1998).

    Google Scholar 

  16. Rutschmann, O. et al. ddI + d4T +/– hydroxyurea for HIV-1 infection. Fifth Conference on Retroviruses and Opportunistic Infections, Chicago, Illinois, 1–5 February 1998.

  17. Montaner, J. et al. A pilot study of hydroxyurea among patients with advanced human immunodeficiency virus (HIV) disease receiving chronic didanosine therapy: Canadian HIV trials network protocol 080. J. Inf. Dis. 175, 801–806 (1997).

    Article  CAS  Google Scholar 

  18. Lori, F., Jessen, H., Foli, A. & Lisziewicz, J. Long-term suppression of HIV-1 by hydroxyurea and didanosine. J. Am. Med. Assoc. 277, 1437–1438 (1997).

    Article  CAS  Google Scholar 

  19. Morris, L. et al. Persistent elevation of HIV viral load during therapy for tuberculosis. Fifth Conference on Retroviruses and Opportunistic Infectios, Chicago, Illinois, 1–5 February 1998.

  20. van Praag, E., Cahn, P. & Kallings, L. The implications of antiretroviral treatments. Report of an international consultation at WHO, Geneva. IAS Newsletter 8, 6–7 (1997).

    Google Scholar 

Download references

Acknowledgements

We thank J. Moore and M. Rossner for suggestions and comments.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morris, L., Martin, D., Quinn, T. et al. The importance of doing HIV research in developing countries. Nat Med 4, 1228–1229 (1998). https://doi.org/10.1038/3206

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/3206

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing